Add BrightSurf on Google Email

Damon Runyon Cancer Research Foundation awards $3.2 million to innovative early-career scientists

The foundation awarded $400,000 over two years to five early-career researchers and continuation support to three current Innovators with significant progress on their proposed research. The recipients focus on developing targeted therapeutics, decoding dendritic cell function, defining NKT cell interactions with tumors, engineering T ...

Innovative review reveals overlooked complexity in cellular energy sensor's dual roles in Alzheimer's disease

A comprehensive review synthesizes emerging evidence on AMPKα isoforms' dual roles in Alzheimer's disease. The analysis proposes that this complexity may explain why pharmacological approaches have yielded mixed results in treating the disease. Isoform-specific targeting is proposed as a novel therapeutic strategy.

SourceGenomic Press·JournalBrain Medicine·TypeLiterature review·DateJan 6, 2026

Resetting the fight-or-flight response

Researchers at Penn State have discovered a mechanism that resets the molecular cycle involved in the fight-or-flight response to stress and starvation. The study used imaging, structural, and biochemical techniques to uncover how this cycle completes and the system resets itself.

SourcePenn State·JournalJournal of the American Chemical Society·DateMay 29, 2025

Reporters broadcast live, on-the-scene, inside living cells

Researchers from Rice University and Princeton University have developed a new technology that allows for the live monitoring of signaling protein networks in living cells. The 'live reporter' system uses unobtrusive proteins to tag specific proteins, which can activate fluorescent markers when they become phosphorylated.

SourceRice University·JournaleLife·TypeExperimental study·DateJul 10, 2023

Harnessing the heart regeneration ability of marsupials

Researchers at RIKEN have discovered how marsupials' hearts can regenerate for several weeks after birth, allowing for potential treatment of human heart disease. They found that inhibiting a protein called AMPK extended the period of regeneration in both mice and opossums, with minimal scarring.

SourceRIKEN·JournalCirculation·DateAug 19, 2022